SM

Shailja Monga

Active Director Director DIN 01686613
DIN 01686613 First appointment Sep 1995 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 1995
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailja Monga

Data last updated:

Shailja Monga is a Director at Kumar Drug Pharmaceuticals Pvt Ltd (since 1995). The company operates in Chemicals.

DIN 01686613
Primary Designation Director
Industry Chemicals
First Appointment 22 Sep 1995
Oldest Company Age 34 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kumar Drug Pharmaceuticals Pvt Ltd U24232PB1992PTC012395
Director22 Sep 19951992Active

Board colleagues of Shailja Monga

NameDINCompanyDesignation
Janak Rani Monga01686622Kumar Drug Pharmaceuticals Pvt LtdDirector
Rajesh Monga01686595Kumar Drug Pharmaceuticals Pvt LtdManaging Director

Directorship timeline

Open interactive timeline →
Kumar Drug Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Shailja Monga

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailja Monga

Shailja Monga currently holds 1 directorship: Kumar Drug Pharmaceuticals Pvt Ltd (Director, since 22 Sep 1995).

Shailja Monga was first appointed on 22 Sep 1995 as Director at Kumar Drug Pharmaceuticals Pvt Ltd.

The current boards of Shailja Monga's companies include Janak Rani Monga (Kumar Drug Pharmaceuticals Pvt Ltd), Rajesh Monga (Kumar Drug Pharmaceuticals Pvt Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available